Matthew Scott Harris insider trades
Open-market stock purchases and sales by Matthew Scott Harris, Chief Medical Officer at Altimmune, Inc, from SEC Form 4 filings since Sep 9, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -23%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ALT Altimmune, Inc: 1 buy, 2 sales, last Jul 31, 2025
Get free alerts when Matthew Scott Harris files a new trade →